|
- 2018
First-generation versus second-generation long-acting injectable antipsychotic drugs and time to relapseKeywords: Depot, antipsychotic, schizophrenia, efficacy Abstract: The development of long-acting injectable formulations (LAIs) of second-generation antipsychotic drugs (SGAs) has been suggested as having advantage over first-generation antipsychotic (FGA) LAIs. In this study, we investigated the hypothesis that there was a longer time to relapse in patients with schizophrenia started on SGA LAI versus FGA LAI
|